Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Voltron Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Voltron Therapeutics

Voltron Therapeutics

Voltron Therapeutics: Specializing in precision-guided vaccines for cancer and infectious diseases.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Voltron Therapeutics, founded as a Delaware corporation, focuses on developing precision-guided, self-assembling vaccines aimed at enhancing cell-mediated responses to combat cancer and infectious diseases, including COVID-19. Utilizing the proprietary VaxCelerate™ Self-Assembling Vaccine Design, developed by specialists at Massachusetts General Hospital (MGH) and the Vaccine & Immunotherapy Center, Voltron Therapeutics aims to revolutionize vaccine development and improve public health outcomes.

Notable affiliations include an exclusive licensing agreement with Massachusetts General Hospital for the VaxCelerate™ technology. Key achievements include significant advancements in vaccine design and development, particularly in addressing urgent health threats like COVID-19. Voltron Therapeutics' impact is marked by its innovative approach to vaccine creation, potentially offering more effective and targeted immunization solutions for some of the most challenging diseases.

Voltron Therapeutics - Similar Companies

VLP Therapeutics logo

VLP Therapeutics

VitriVax logo

VitriVax

vitrivaxbio.com

Virion Therapeutics logo

Virion Therapeutics

viriontx.com

VaxEquity logo

VaxEquity

Volastra Therapeutics logo

Volastra Therapeutics

volastratx.com

Innovac Therapeutics logo

Innovac Therapeutics

innovactx.com

CellVax Therapeutics logo

CellVax Therapeutics

cellvx.com

Attivare Therapeutics logo

Attivare Therapeutics

Vaxxinity logo

Vaxxinity

vaxxinity.com

Calder Biosciences logo

Calder Biosciences

Solaris Vaccines logo

Solaris Vaccines

solarisvax.com

X-Vax Technology logo

X-Vax Technology

Vaccinex logo

Vaccinex

vaccinex.com

Thyreos logo

Thyreos

Vivaldi Biosciences logo

Vivaldi Biosciences

Voltron Therapeutics - Quick Facts

Who are Voltron Therapeutics' competitors?

Companies similar to Voltron Therapeutics include VLP Therapeutics, VitriVax, Virion Therapeutics and VaxEquity.

When was Voltron Therapeutics founded?

Voltron Therapeutics was founded in 2017.

Where is Voltron Therapeutics' headquarters located?

Voltron Therapeutics' headquarters is located in New York City, NY, US.

When was Voltron Therapeutics' last funding round?

Voltron Therapeutics' most recent funding round was for $5.9M (USD) in August 2023.

How much has Voltron Therapeutics raised to-date?

As of Aug 17, 2023, Voltron Therapeutics has raised a total of $5.9M (USD).

How many employees does Voltron Therapeutics have?

Voltron Therapeutics has 9 employees as of Feb 5, 2024.

Voltron Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Vaccines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified